Chromosomal instability and cancer: Insights into the role of replicative stress;L'oncogénomique: Chroniques d'un avènement (2): Instabilité chromosomique et cancer, enfin des CIN révé lateurs

Medecine/Sciences

Volumn 29, Issue 8-9, 2013, Pages 807-810

  Le Borgne, Maïlys ^a   Chartier, Nicolas ^a   Billaud, Marc ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANEUPLOIDY; CELL AGING; CHROMOSOMAL INSTABILITY; DNA DAMAGE; GENETICS; HETEROZYGOSITY LOSS; HUMAN; NEOPLASM; REVIEW; TUMOR SUPPRESSOR GENE;

ANEUPLOIDY; CELL AGING; CHROMOSOMAL INSTABILITY; DNA DAMAGE; GENES, TUMOR SUPPRESSOR; HUMANS; LOSS OF HETEROZYGOSITY; NEOPLASMS;

EID: 84884629931     PISSN: 07670974     EISSN: 19585381     Source Type: Journal    
DOI: 10.1051/medsci/2013298022     Document Type: Article

References (13)

1. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998; 396: 643-9.
2. Kops GJPL, Weaver BAA, Cleveland DW. On the road to cancer: aneuploidy and the mitotic checkpoint. Nat Rev Cancer 2005; 5: 773-85.
3. Burrell RA, McClelland SE, Endesfelder D, et al. Replication stress links structural and numerical cancer chromosomal instability. Nature 2013; 494: 492-6.
4. Bartkhova J, Rezaei N, Liontos M, et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 2006; 444: 633-7.
5. Bunz F, Fauth C, Speicher MR, et al. Targeted inactivation of p53 in human cells does not result in aneuploidy. Cancer Res 2002; 62: 1129-33.
6. Anglana M, Apiou F, Bensimon A, Debatisse M. Dynamics of DNA replication in mammalian somatic cells: nucleotide pool modulates origin choice and interorigin spacing. Cell 2003; 114: 385-94.
7. Bester AC, Roniger M, Oren YS, et al. Nucleotide deficiency promotes genomic instability in early stages of cancer development. Cell 2011; 145: 435-46.
8. Billaud M. L'hétérogénéité intratumorale, un obstacle darwinien à la médecine personnalisée? Med Sci (Paris) 2012; 12: 1116-9.
9. Maydan G, Noyman I, Har-Zahav A, et al. Multiple congenital anomalieshypotonia seizures syndrome is caused by a mutation in PIGN. J Med Genet 2011; 48: 383-9.
10. Krawitz PM, Schweiger MR, Rödelsperger C, et al. Identity-by-descent filtering of exome sequence data identifies PIGV mutations in hyperphosphatasia mental retardation syndrome. Nat Genet 2010; 42: 827-9.
11. Krawitz PM, Murakami Y, Hecht Y, et al. Mutations in PIGO, a member of the GPIanchor-synthesis pathway, cause hyperphosphatasia with mental retardation. Am J Hum Genet 2012; 91: 146-51.
12. Buchet-Poyau H, Courchet J, Le Hir H, et al. Identification and characterization of human Mex-3 proteins, a novel family of evolutionarily conserved RNAbinding proteins differentially localized to processing bodies. Nucleic Acids Res 2007; 35: 1289-1300.
13. Topol E. The creative destruction of medicine. New York: Basic Books, 2012.